Hourly refreshFri, Oct 30, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Finance

12,101 press releases in English indexed under finance.

Clear all filters
Keywords, dates and language
Sources
up to 10
Newswires (50)
Company newsrooms (91)
Companies
Releases linked to any of up to 10 companies
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
DownloadExcelTXT
Finance

OpenText Announces Pricing Terms and Results of Cash Tender Offer

WATERLOO, ON, Sept. 30, 2026 -- Open Text Corporation ("OpenText" or the "Company") (NASDAQ: OTEX), (TSX: OTEX) today announced the pricing terms and results of its previously announced tender offer (the "Tender Offer") to purchase for cash up to $300,000,000 aggregate...

Sep 30 · 22:40PR Newswire
Finance

Pulse Seismic Reports Strong Preliminary Third Quarter 2026 Revenue

CALGARY, Alberta, Sept. 30, 2026 -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) today announced preliminary third quarter 2026 revenue results. The Company expects to issue and file its financial results for the three and nine months ended September 30, 2026 on SEDAR+ (www.sedarplus.ca) and will make them available on Pulse’s website at www.pulseseismic.com after markets close on October 21, 2026.

Sep 30 · 22:30GlobeNewswire
Finance · Travel

NCL Corporation Ltd. Announces Upsizing and Pricing of $950.0 Million of Senior Notes

MIAMI, Sept. 30, 2026 -- NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”), announced today that it has priced $950.0 million aggregate principal amount of its 8.750% senior notes due 2031 (the “Notes”), which were offered in a private offering (the “Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of Notes to be issued was increased to $950.0 million from the previously announced $750.0 million.

Sep 30 · 22:12GlobeNewswire
Finance

Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from the Phase 3 ACHIEVE-4 trial evaluating...

Sep 30 · 22:00Eli Lilly and Company
Finance

Application for an Exploration and Production Licence in the Faroe Islands under the Open Door Licensing Regime

Tórshavn, Faroe Islands, 2026-09-30 -- Today P/F Atlantic Petroleum (Nasdaq Copenhagen: ATLA DKK) has submitted an Application for an Exploration and Production Licence in the Faroe Islands under the Open Door Licensing Regime.

Sep 30 · 21:49GlobeNewswire
Finance · Biotech & pharma

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GLEN ALLEN, Va., Sept. 30, 2026 -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option to purchase 155,446 shares of common stock as an inducement to such person becoming an employee of the Company.

Sep 30 · 21:46GlobeNewswire
Finance

MacKenzie Realty Capital Reports FY 2026 Financial Results and Announces Suspension of Preferred Share Repurchase Program while Exploring Strategic Transactions

ORINDA, Calif., Sept. 30, 2026 -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced its financial results for the year ended June 30, 2026 and announced that its Board has temporarily suspended the Preferred Share Repurchase Program while it explores strategic transactions such as reverse takeovers.

Sep 30 · 21:46GlobeNewswire
Finance

Automatic Securities Disposition Plan Adopted by Xanadu Chief Operating Officer

TORONTO, Sept. 30, 2026 -- Xanadu Quantum Technologies Limited (“Xanadu”; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, today announced that Rafal Janik, Xanadu's Chief Operating Officer, has entered into an automatic securities disposition plan (the “Plan”) to sell Class B Subordinate Voting Shares of Xanadu ("Class B Shares") held directly by Mr. Janik. The Plan has been adopted in accordance with applicable securities laws and Xanadu’s internal policies. Sales of Class B Shares under the Plan are eligible to commence on or after December 29, 2026.

Sep 30 · 21:40GlobeNewswire
Finance · Healthcare

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference

NEW YORK, Sept. 30, 2026 -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a clinical stage biotechnology company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, Prader-Willi Syndrome, depression, and other central nervous system (CNS) disorders, today announced that it will participate in the Foundation for Prader-Willi Research (FPWR) 2026 Research Symposium, October 7-8, and the PWS Family Conference, October 9-10, at the Marriott Philadelphia Downtown.

Sep 30 · 21:30GlobeNewswire
Finance

Aeroméxico Announces Webcast of Third Quarter 2026 Financial Results

MEXICO CITY, Sept. 30, 2026 -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Tuesday, October 20, 2026, at 8:00 a.m. Mexico City Time (10:00 a.m. Eastern Time) to discuss its third quarter 2026 financial results.

Sep 30 · 21:30GlobeNewswire
Finance · Biotech & pharma

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

– Financing includes leading U.S. biotechnology institutional investors and mutual funds – – Financing includes leading U.S. biotechnology institutional investors and mutual funds –

Sep 30 · 21:15GlobeNewswire
Finance

Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 30, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

Sep 30 · 21:12GlobeNewswire